Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Long-Term Debt Repayments (2016 - 2022)

Jaguar Health (JAGX) has disclosed Long-Term Debt Repayments for 7 consecutive years, with $447000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Long-Term Debt Repayments rose 794.0% to $447000.0 in Q1 2022 year-over-year; TTM through Mar 2023 was $497000.0, a 0.0% change, with the full-year FY2021 number at $100000.0, down 75.37% from a year prior.
  • Long-Term Debt Repayments was $447000.0 for Q1 2022 at Jaguar Health, up from $50000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.7 million in Q1 2018 to a low of -$2.7 million in Q4 2020.
  • A 5-year average of $274220.0 and a median of $75000.0 in 2019 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: plummeted 100.0% in 2018, then skyrocketed 794.0% in 2022.
  • Jaguar Health's Long-Term Debt Repayments stood at $1.0 in 2018, then surged by 9999900.0% to $100000.0 in 2019, then tumbled by 2834.0% to -$2.7 million in 2020, then soared by 101.83% to $50000.0 in 2021, then surged by 794.0% to $447000.0 in 2022.
  • Per Business Quant, the three most recent readings for JAGX's Long-Term Debt Repayments are $447000.0 (Q1 2022), $50000.0 (Q3 2021), and $50000.0 (Q1 2021).